SUVEN — Suven Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Suven Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	464	504	2,284	2,399	600
Net Total Accounts Receivable
Net Total Receivables	550	147	206	155	26
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,027	666	2,516	2,567	755
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	256	409	370	280	595
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,284	1,080	3,889	2,849	1,352
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	159	83.1	111	135	235
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	204	119	136	149	252
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,080	961	3,753	2,700	1,100
Total Liabilities & Shareholders' Equity	1,284	1,080	3,889	2,849	1,352
Total Common Shares Outstanding